InsiderClue
← All stocks

Gain Therapeutics, Inc.

GANX Net buying
CIK 0001819411 #4414 in the set updated 22 Sep 2026
Bought (120 mo)
$24.54M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$5.06K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$5.06K
2 of 2 sales
Net
+$24.54M
+$24.54M against sales at will

By person

6 insiders · 12 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Calabrese Salvatore
Chief Financial Officer
$24.30M (1)
—
+$24.30M
—
—
—
—
Riley Jeffrey Scott
Director
$115.77K (1)
—
+$115.77K
30,000
0.0687%
$29.96K
—
RICHMAN ERIC I
Director
$64.11K (5)
—
+$64.11K
289,629
0.6636%
$289.28K
+47.0%
Islam Khalid
Director
$49.94K (1)
—
+$49.94K
50,000
0.1146%
$49.94K
—
Mack Gene
CEO, President
$14.54K (1)
—
+$14.54K
14,400
0.0330%
$14.38K
—
Alder Matthias
Chief Executive Officer
—
$5.06K (2)
−$5.06K
21,140
0.0484%
$21.11K
+1,124%

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Islam Khalid
9 Aug 2024
Executive Chairman
Buy
50,000
$1.00
$49.94K
Mack Gene
9 Aug 2024
CFO and Interim CEO
Buy
14,400
$1.01
$14.54K
RICHMAN ERIC I
1 Jul 2024
Director
Buy
12,000
$1.21
$14.52K
RICHMAN ERIC I
1 Jul 2024
Director
Buy
5,000
$1.23
$6.15K
Riley Jeffrey Scott
28 Mar 2024
Director
Buy
30,000
$3.86
$115.77K
Alder Matthias
21 Dec 2023
Chief Executive Officer
Sell
206
$2.46
$506.76
Alder Matthias
7 Dec 2023
Chief Executive Officer
Sell
1,820
$2.50
$4.55K
RICHMAN ERIC I
25 May 2022
CHIEF EXECUTIVE OFFICER
Buy
2,482
$2.58
$6.40K
RICHMAN ERIC I
20 May 2022
CHIEF EXECUTIVE OFFICER
Buy
9,256
$2.83
$26.19K
Calabrese Salvatore
19 May 2022
CHIEF FINANCIAL OFFICER
Buy
3,000
$8,100.00
$24.30M
RICHMAN ERIC I
19 May 2022
CHIEF EXECUTIVE OFFICER
Buy
4,000
$2.71
$10.84K
RICHMAN ERIC I
16 Aug 2021
Director
Exercised, kept
4,922
$7.87
$38.72K

What was left out

Form 4 filings counted 64
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 93,431
History held since 17 Aug 2021